Nina Lin, MD
Assistant Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
Infectious Diseases

MD, Harvard Medical School
BS, Stanford University



Dr. Nina Lin is a physician scientist who is engaged in HIV translational research. Her research is focused on understanding the effect of chronic HIV infection on aging of the immune system and chronic inflammation. She is the PI on several clinical trials, including being a co-Chair of ACTG A5325 and A5220s, to evaluate interventions which may improve or alter the clinical course of chronic HIV infection. Her research while at MGH/BWH had been on understanding HIV-1 coreceptor usage in subtype C infection and the factors associated with its switching. She is the Director of the BU Infectious Disease Clinical Research Unit (CRU) where several HIV and/or infectious diseases clinical studies are being conducted.


Impact of smoking and its cessation on systemic and airway immune activation
08/15/2016 - 06/30/2018 (Co-Investigator)
Boston Medical Center Corporation NIH NIDA
5R01DA042685-02


The Effects of Opiod Use on HIV-1 Reservoir Dynamics
08/15/2018 - 05/31/2024 (PI)
Brigham and Womens Hospital National Institute o
5R61DA047038-03

Tocilizumab to Prevent the Progression of Hypoxemic Respiratory Failure in Hospitalized…
04/30/2020 - 04/30/2024 (PI)
Massachusetts General Hospital Genentech, Inc.

Impact of smoking and its cessation on systemic and airway immune activation
07/01/2019 - 12/31/2023 (PI)
National Institute on Drug Abuse/NIH/DHHS National Heart, Lung
5R01DA042685-03

Rapid Bacterial Identification (RABIT) Study
08/01/2019 - 10/31/2023 (PI)
Day Zero Diagnostics, Inc.

Intensified antiretroviral therapy with raltegravir in acute HIV infection to limit establishment…
01/01/2020 - 06/30/2023 (PI)
Merck

Providence Boston Center for AIDS Research (CFAR)
07/01/2019 - 06/30/2023 (Multi-PI)
PI: Nina Lin, MD
The Miriam Hospital National Institute o
5P30AI042853-24

A PHASE III, RANDOMIZED, DOUBLE-BLIND,MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF REMDESIVIR PLUS TOCILIZUMAB COMPARED WITH REMDESIVIR PLUS PLACEBO IN HOSPITALIZED PATIENTS WITH SEVERE COVID-19 PNEUMONIA
06/28/2020 - 06/28/2023 (PI)
Genentech, Inc.

SALSA 208090 A Phase III, randomized, multicenter, open-label, non-inferiority study evaluating…
03/06/2020 - 10/17/2022 (PI)
ViiV Healthcare

GS-US-380-4580 A Phase 3b, Multicenter, Open-Label Study to Evaluate Switching From a Regimen of…
01/01/2019 - 03/31/2022 (PI)
Gilead Sciences

PILOT STUDY - EFFECTS OF BICTEGRAVIR-EMTRICITABINE-TENOFOVIR ALAFENAMIDE ON CORONARY FLOW RESERVE…
01/01/2019 - 03/31/2022 (PI)
Brigham and Womens Hospital

Showing 10 of 28 results. Show All Results

Title


Yr Title Project-Sub Proj Pubs
2022 Persistent HIV expression induced type I IFN responses and inflammaging 5R01AG060890-05
2021 Persistent HIV expression induced type I IFN responses and inflammaging 5R01AG060890-04 2
2021 Impact of smoking and its cessation on systemic and airway immune activation 5R01DA042685-05
2020 The effects of opioid use on HIV-1 reservoir dynamics 5R61DA047038-03
2020 Persistent HIV expression induced type I IFN responses and inflammaging 5R01AG060890-03 2
2020 Impact of smoking and its cessation on systemic and airway immune activation 5R01DA042685-04
2019 The effects of opioid use on HIV-1 reservoir dynamics 5R61DA047038-02
2019 Persistent HIV expression induced type I IFN responses and inflammaging 5R01AG060890-02 2
2019 Impact of smoking and its cessation on systemic and airway immune activation 5R01DA042685-03
2018 The effects of opioid use on HIV-1 reservoir dynamics 1R61DA047038-01
Showing 10 of 19 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. McLaughlin A, Lin N, Jiang W, Lodi S, Lioznov D, Patts G, Gnatienko N, Blokhina E, Bendiks S, Freiberg MS, Tindle HA, Krupitsky E, Hahn JA, Samet JH, So-Armah K. Association of Alcohol Consumption With CD4 Recovery After Antiretroviral Therapy Initiation in St. Petersburg, Russia. J Acquir Immune Defic Syndr. 2023 Nov 01; 94(3):244-252.View Related Profiles. PMID: 37850982; PMCID: PMC10593489; DOI: 10.1097/QAI.0000000000003250;
     
  2. Asundi A, Olson A, Jiang W, Varshney SP, White LF, Sagar M, Lin NH. Integrase Inhibitor Use Associated with Weight Gain in Women and Incident Diabetes Mellitus. AIDS Res Hum Retroviruses. 2022 03; 38(3):208-215.View Related Profiles. PMID: 34877881; PMCID: PMC8968841; DOI: 10.1089/aid.2021.0091;
     
  3. Kuniholm J, Armstrong E, Bernabe B, Coote C, Berenson A, Patalano SD, Olson A, He X, Lin NH, Fuxman Bass JI, Henderson AJ. Intragenic proviral elements support transcription of defective HIV-1 proviruses. PLoS Pathog. 2021 12; 17(12):e1009982.View Related Profiles. PMID: 34962974; PMCID: PMC8746790; DOI: 10.1371/journal.ppat.1009982;
     
  4. Ragan EJ, McCallum C, Marathe J, Cole M, Hofman M, Henderson AJ, Flack T, Miller NS, Burks EJ, Zhao GQ, Denis R, Lin NH, Jacobson KR, Andry CD, Pelton SI, Duffy ER, Bhadelia N. Pandemic Response Requires Research Samples: A U.S. Safety-Net Hospital's Experience and Call for National Action. Ann Intern Med. 2021 12; 174(12):1727-1732.View Related Profiles. PMID: 34724402; DOI: 10.7326/M21-2857;
     
  5. Olson A, Coote C, Snyder-Cappione JE, Lin N, Sagar M. HIV-1 Transcription but Not Intact Provirus Levels are Associated With Systemic Inflammation. J Infect Dis. 2021 06 04; 223(11):1934-1942.View Related Profiles. PMID: 33075121; PMCID: PMC8176637; DOI: 10.1093/infdis/jiaa657;
     
  6. Kamel MH, Mahmoud H, Zhen A, Liu J, Bielick CG, Mostaghim A, Lin N, Chitalia V, Ilori T, Waikar SS, Upadhyay A. End-stage kidney disease and COVID-19 in an urban safety-net hospital in Boston, Massachusetts. PLoS One. 2021; 16(6):e0252679.View Related Profiles. PMID: 34086775; PMCID: PMC8177422; DOI: 10.1371/journal.pone.0252679;
     
  7. Yuen RR, Steiner D, Pihl RMF, Chavez E, Olson A, Smith EL, Baird LA, Korkmaz F, Urick P, Sagar M, Berrigan JL, Gummuluru S, Corley RB, Quillen K, Belkina AC, Mostoslavsky G, Rifkin IR, Kataria Y, Cappione AJ, Gao W, Lin NH, Bhadelia N, Snyder-Cappione JE. Novel ELISA Protocol Links Pre-Existing SARS-CoV-2 Reactive Antibodies With Endemic Coronavirus Immunity and Age and Reveals Improved Serologic Identification of Acute COVID-19 via Multi-Parameter Detection. Front Immunol. 2021; 12:614676.View Related Profiles. PMID: 33897682; PMCID: PMC8062931; DOI: 10.3389/fimmu.2021.614676;
     
  8. Stone JH, Frigault MJ, Serling-Boyd NJ, Fernandes AD, Harvey L, Foulkes AS, Horick NK, Healy BC, Shah R, Bensaci AM, Woolley AE, Nikiforow S, Lin N, Sagar M, Schrager H, Huckins DS, Axelrod M, Pincus MD, Fleisher J, Sacks CA, Dougan M, North CM, Halvorsen YD, Thurber TK, Dagher Z, Scherer A, Wallwork RS, Kim AY, Schoenfeld S, Sen P, Neilan TG, Perugino CA, Unizony SH, Collier DS, Matza MA, Yinh JM, Bowman KA, Meyerowitz E, Zafar A, Drobni ZD, Bolster MB, Kohler M, D'Silva KM, Dau J, Lockwood MM, Cubbison C, Weber BN, Mansour MK. Efficacy of Tocilizumab in Patients Hospitalized with Covid-19. N Engl J Med. 2020 12 10; 383(24):2333-2344.View Related Profiles. PMID: 33085857; PMCID: PMC7646626; DOI: 10.1056/NEJMoa2028836;
     
  9. Sinha P, Mostaghim A, Bielick CG, McLaughlin A, Hamer DH, Wetzler LM, Bhadelia N, Fagan MA, Linas BP, Assoumou SA, Ieong MH, Lin NH, Cooper ER, Brade KD, White LF, Barlam TF, Sagar M. Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge. Int J Infect Dis. 2020 Oct; 99:28-33.View Related Profiles. PMID: 32721528; PMCID: PMC7591937; DOI: 10.1016/j.ijid.2020.07.023;
     
  10. Registre L, Moreau Y, Ataca ST, Pulukuri S, Henrich TJ, Lin N, Sagar M. HIV-1 Coreceptor Usage and Variable Loop Contact Impact V3 Loop Broadly Neutralizing Antibody Susceptibility. J Virol. 2020 01 06; 94(2).View Related Profiles. PMID: 31694950; PMCID: PMC6955257; DOI: 10.1128/JVI.01604-19;
     
Showing 10 of 31 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 27 publications over 16 distinct years, with a maximum of 5 publications in 2021

YearPublications
19921
19932
19951
19981
20102
20111
20122
20131
20151
20161
20182
20192
20203
20215
20221
20231
Contact for Mentoring:

650 Albany St Evans Biomed Research Ctr
Boston MA 02118
Google Map


Lin's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department